Atrial-selective sodium channel block for the treatment of atrial fibrillation

Author： Burashnikov Alexander   Antzelevitch Charles  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.14, Iss.2, 2009-06, pp. : 233-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation

By Tamargo Juan   Caballero Ricardo   Gómez Ricardo   Delpón Eva  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 399-416

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Approaches in the Treatment of Atrial Fibrillation

By  

Current Medicinal Chemistry, Vol. 11, Iss. 1, 2004-01 ,pp. : 13-28

Bentham Science Publishers

Access to resources Recommend Favorite

Vernakalant for the Conversion of Atrial Fibrillation: The New Kid On the Block?

By Conde Diego   Baranchuk Adrian  

Annals of Noninvasive Electrocardiology, Vol. 19, Iss. 4, 2014-07 ,pp. : 299-302

Blackwell Publishing

Access to resources Recommend Favorite

Renin-Angiotensin System Block and Atrial Fibrillation

By  

Current Medicinal Chemistry, Vol. 12, Iss. 11, 2005-06 ,pp. : 1331-1337

Bentham Science Publishers

Access to resources Recommend Favorite

Polymorphism H558R in the Human Cardiac Sodium Channel SCN5A Gene is Associated with Atrial Fibrillation

By Chen L   Zhang W   Fang C   Jiang S   Shu C   Cheng H   Li F   Li H  

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1908-1916

Field House Publishing

Access to resources Recommend Favorite